Contact: Gail Porter
National Institute of Standards and Technology (NIST)
Caption: A new NIST-sponsored study found that the biopharmaceutical industry spend a total of $1,219 million on infrastructure technology?884 million on the R&D technology infrastructure including bioimaging, biomarkers, informatics, and gene expression and $335 million on infrastructure for commercial manufacturing and postmarket surveillance.
Usage Restrictions: None
Related news release: Biopharmaceutical infrastructure key to lower drug development costs